SCHEMBL28157400

SCHEMBL28157400

Cc1cc(NC(=O)c2ccccc2F)sc1S(=O)(=O)N1CCOCC1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.60
▸ POLB P06746 2/20 0.56
▸ TSHR P16473 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ CREBBP Q92793 1/20 0.51
▸ CNR1 P21554 1/20 0.50
▸ CNR2 P34972 1/20 0.50
▸ TP53 P04637 2/20 0.48
▸ KDM1A O60341 1/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ USP2 O75604 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28156730 0.87 KDM4E (0.49) MAPTPOLBTSHRSMN1; SMN2HSD17B10
SCHEMBL28157299 0.82 MAPT (0.66) MAPTPOLBTSHRSMN1; SMN2HSD17B10
SCHEMBL16246265 0.81 MAPT (0.56) MAPTPOLBTSHRSMN1; SMN2HSD17B10
SCHEMBL28846328 0.77 HPGD (0.48) MAPTPOLBSMN1; SMN2HSD17B10TP53
SCHEMBL16088763 0.75 MAPT (0.62) MAPTPOLBTSHRSMN1; SMN2HSD17B10
SCHEMBL16246474 0.75 MAPT (0.59) MAPTPOLBTSHRSMN1; SMN2HSD17B10
SCHEMBL28157282 0.73 MAPT (0.52) MAPTTSHRSMN1; SMN2MAPK1TP53
SCHEMBL28846473 0.72 TSHR (0.51) MAPTPOLBTSHRSMN1; SMN2HSD17B10
SCHEMBL16387392 0.72 FLT3 (0.51) MAPTPOLBTSHRSMN1; SMN2HSD17B10
SCHEMBL28157411 0.71 KDM1A (0.55) MAPTPOLBSMN1; SMN2HSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-B Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis 加拉佩格斯股份有限公司 2017-09-12 — — CN disclosed
Send feedback